Skip to main content

AsclepiX Therapeutics, Inc., Raises $35M for Blindness-Fighting Therapies

AsclepiX Therapeutics, Inc. , a Baltimore City-based biopharmaceutical company out of The Johns Hopkins University, has raised $35M in new Series A funding to support development of blindness-fighting therapies. According to the Baltimore Business Journal, the new financing will be used to fund clinical trials of AsclepiX's lead therapy candidate which will launch this year. The company has three additional therapies in its development pipeline targeting ocular diseases and cancer. #regiononpoint #healthcare #lifesciences #investment #biopharma #blindness #cancer

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927